Anticoagulation in nonvalvular atrial fibrillation

被引：0

作者：

Nagra, Bipinpreet S. ^{[1
]}

Kantharia, Bharat K. ^{[1
]}

机构：

[1] Albert Einstein Med Ctr, Div Cardiac Electrophys, 5501 Old York Rd,Levy 3 East, Philadelphia, PA 19118 USA

来源：

FUTURE CARDIOLOGY | 2005年 / 1卷 / 03期

关键词：

anticoagulation; aspirin; atrial fibrillation; coumadin; stroke; thromboembolism; warfarin;

D O I：

10.1517/14796678.1.3.373

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation is the most common, serious, cardiac arrhythmia and increases the risk for ischemic stroke fivefold. Nonvalvular atrial fibrillation may be responsible for up to 15-20% of strokes. Antiplatelet agents and oral anticoagulants are used for stroke prevention in atrial fibrillation. The following review article discusses the potential risks and benefits of oral anticoagulants in nonvalvular atrial fibrillation with particular emphasis on accurate risk stratification tools for ischemic stroke.

引用

页码：373 / 380

页数：8

共 45 条

[1]

Albers GW, 2004, STROKE, V35, P242

[2]

Albers GW, 2003, LANCET, V362, P1691

[3]

Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273

[4]

Atrial Fibrillation Investigators, 1998, ARCH INTERN MED, V158, P1316

[5]

Atrial Fibrillation Investigators, 1994, ARCH INTERN MED, V154, P1449

[6]

Benavente O, 2004, COCHRANE DATABASE SY, V4

[7]

Blackshear JL, 1996, LANCET, V348, P633

[8] PATHOGENESIS OF ANTERIOR CIRCULATION STROKE IN PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION - THE LAUSANNE-STROKE-REGISTRY [J].

BOGOUSSLAVSKY, J ;

VANMELLE, G ;

REGLI, F ;

KAPPENBERGER, L .

NEUROLOGY, 1990, 40 (07) :1046-1050

[9]

Camm A J, 1996, Am J Cardiol, V78, P3, DOI 10.1016/S0002-9149(96)00559-0

[10] CANADIAN ATRIAL-FIBRILLATION ANTICOAGULATION (CAFA) STUDY [J].

CONNOLLY, SJ ;

LAUPACIS, A ;

GENT, M ;

ROBERTS, RS ;

CAIRNS, JA ;

JOYNER, C .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) :349-355

← 1 2 3 4 5 →